NDT Pharmaceuticals Inc.

NDT Pharmaceuticals Inc.

NDTP - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$21M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
NDT Pharmaceuticals Inc.NDT Pharmaceuticals Inc.-20.9--3%--
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$21.00 Million
Enterprise Value$21.62 Million
Earnings per Share$0
Beta0
Outstanding Shares197,504,349

Return

Return on Equity-2.61%ROE
Return on Assets-2.55%
Return on Invested Capital-2.56%

Valuation & Multiples

P/E Ratio-20.88P/E Ratio
PEG-0.09PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue77.65
Enterprise Value to EBIT-21.24
Enterprise Value to Net Income-22
Total Debt to Enterprise0.03
Debt to Equity0.02Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About NDT Pharmaceuticals Inc.

0
CEO: James Hovis

NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.